InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: None

Thursday, 08/16/2012 12:36:38 PM

Thursday, August 16, 2012 12:36:38 PM

Post# of 3720
Vator...you CANNOT tell us ("you") that they months or years away from End Liver Disease trials.

As noted, unless you have inside information, you have no idea if they are in the process of duplicating the agreement which they had with U of Miami (without escape clause) for a bigger piece of the action or if they are engaged in partnership with a major pharmacological...which "research report" alluded to as possible fit and suitor Celgene.

Very misleading comments based on prior ability of company to get partner and possible discussions...we dont know what they are doing behind the scene.

With FDA "permission" to proceed, the question of what the SEC is looking at eliminates the substance of their technology....so must be other issues looking at ...no doubt complaints by shareholders of stock movement.